School of Medicine
Showing 1-10 of 164 Results
Benjamin Pooya Fahimian
Clinical Associate Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly Interests Brachytherapy (Prostate, Gynecological, and Ocular Carcinoma)
High Dose Rate Brachytherapy Delivery Techniques
Trajectory Modulated Arc Therapy
Total Body and Total Skin Irradiation Techniques
Image Guided Radiotherapy
Professor of Obstetrics and Gynecology, Emeritus
Current Research and Scholarly Interests Gynecologic and obstetric infections.
Robert Michael Fairchild
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Bio Dr. Fairchild specializes in the diagnosis, evalaution and management of rheumatologic diseases. He has a particular interest in musculoskeletal ultrasound and heads the Division of Immunology and Rheumatology's Diagnostic and Interventional Musculoskeletal Ultrasound Clinic. Dr. Fairchild, received his Ph.D. from Georgetown University, and his M.D. from Columbia University College of Physicians and Surgeons. He completed internship and residency in the Department of Medicine at Stanford University. He continued on at Stanford, completing his fellowship in rheumatology and subsequently joined the faculty of the Division of Immunology and Rheumatology. He trained in rheumatologic musculoskeletal ultrasound through the USSONAR program and is certified in this technique through the American College of Rheumatology (RhMSUS certification).
Robert W. and Vivian K. Cahill Professor in Cancer Research, Emeritus
Current Research and Scholarly Interests Dr. Falkow is no longer taking students or postdoctoral fellows in his laboratory. He is actively engaged in undergraduate teaching and course development in the medical school
Alice C. Fan
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.